Zika vaccine: Sanofi Pasteur awarded $43 million to develop an inactivated vaccine
by Press Release from Outbreak News Today on (#1W2D4)
The U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced a contract to develop an inactivated vaccine candidate to prevent the Zika virus infection and thereby the associated devastating birth defects. Inactivated vaccines have been shown to be safe and effective when given to ["]
